Systemic inflammatory response syndrome after major abdominal surgery predicted by early upregulation of TLR4 and TLR5

Annals of Surgery

Volumn 263, Issue 5, 2016, Pages 1028-1037

  Lahiri, Rajiv ^a,b   Derwa, Yannick ^a   Bashir, Zora ^a   Giles, Edward ^a   Torrance, Hew D T ^a   Owen, Helen C ^a   O'Dwyer, Michael J ^a   O'Brien, Alastair ^c   Stagg, Andrew J ^a   Bhattacharya, Satyajit ^b   Foster, Graham R ^a   Alazawi, William ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Monocyte; Sepsis; SIRS; Surgery; TLR

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; CD14 ANTIGEN; CD16 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; STAT1 PROTEIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; BIOLOGICAL MARKER; TLR4 PROTEIN, HUMAN; TLR5 PROTEIN, HUMAN;

ABDOMINAL SURGERY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; BILIARY TRACT SURGERY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EX VIVO STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INNATE IMMUNITY; LIVER ABSCESS; LIVER SURGERY; LOWER RESPIRATORY TRACT INFECTION; MAJOR SURGERY; MALE; MONOCYTE; PANCREAS SURGERY; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SERUM; SURGICAL PATIENT; SURGICAL RISK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UPREGULATION; ABDOMEN; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; SURGERY; VERY ELDERLY;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 5; UP-REGULATION;

EID: 84949462474     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001248     Document Type: Article

References (27)

1. Ferraris VA, Ballert EQ, Mahan A. The relationship between intraoperative blood transfusion and postoperative systemic inflammatory response syndrome. Am J Surg. 2013;205:457-465.
2. Comstedt P, Storgaard M, Lassen AT. The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study. Scand J Trauma Resusc Emerg Med. 2009;17:67.
3. Kelly KJ, Greenblatt DY, Wan Y, et al. Risk stratification for distal pancreatectomy utilizing ACS-NSQIP: preoperative factors predict morbidity and mortality. J Gastrointest Surg. 2011;15:250-259; discussion 259-261.
4. Mokart D, Merlin M, Sannini A, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth. 2005;94:767-773.
5. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4: 499-511.
6. Fallon PG, Allen RL, Rich T. Primitive Toll signalling: bugs, flies, worms and man. Trends Immunol. 2001;22:63-66.
7. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410: 1099-1103.
8. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783-801.
9. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H(HeJ and C57BL(10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085-2088.
10. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37-40.
11. Durila M, Bronsky J, Harustiak T, et al. Early diagnostic markers of sepsis after oesophagectomy (including thromboelastography). BMC Anesthesiol. 2012;12:12.
12. Hinrichs C, Kotsch K, Buchwald S, et al. Perioperative gene expression analysis for prediction of postoperative sepsis. Clin Chem. 2010;56:613-622.
13. Mokart D, Capo C, Blache JL, et al. Early postoperative compensatory antiinflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg. 2002;89: 1450-1456.
14. American. American College of Chest Physicians(Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
15. Horan TC, Andrus M, Dudeck MA. CDC(NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332.
16. Torrance HD, Brohi K, Pearse RM, et al. Association between gene expression biomarkers of immunosuppression and blood transfusion in severely injured polytrauma patients. Ann Surg. 2015;261:751-759.
17. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.
18. Dienz O, Rincon M. The effects of IL-6 on CD4 T cell responses. Clin Immunol. 2009;130:27-33.
19. Gaudilliere B, Fragiadakis GK, Bruggner RV, et al. Clinical recovery from surgery correlates with single-cell immune signatures. Sci Transl Med. 2014;6:255ra131.
20. Yarilina A, Ivashkiv LB. Type I interferon: a new player in TNF signaling. Curr Dir Autoimmun. 2010;11:94-104.
21. Khoo JJ, Forster S, Mansell A. Toll-like receptors as interferon-regulated genes and their role in disease. J Interferon Cytokine Res. 2011;31:13-25.
22. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007;81:584-592.
23. Pedraza-Sanchez S, Hise AG, Ramachandra L, et al. Reduced frequency of a CD14+ CD16+ monocyte subset with high Toll-like receptor 4 expression in cord blood compared to adult blood contributes to lipopolysaccharide hyporesponsiveness in newborns. Clin Vaccine Immunol. 2013;20:962-971.
24. Cameron JL, Riall TS, Coleman J, et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10-15.
25. Mukherjee S, Kocher HM, Hutchins RR, et al. Impact of hospital volume on outcomes for pancreaticoduodenectomy: a single UK HPB centre experience. Eur J Surg Oncol. 2009;35:734-738.
26. Opal SM, Laterre PF, Francois B, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309:1154-1162.
27. Shirey KA, LaiW, Scott AJ, et al. The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature. 2013;497:498-502.